These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 7842291)

  • 21. Tissue specificity of anti melanoma monoclonal antibodies analyzed on cell lines.
    Johnson JP; Riethmüller G
    Hybridoma; 1982; 1(4):381-5. PubMed ID: 6208134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen.
    Bumol TF; Chee DO; Reisfeld RA
    Hybridoma; 1982; 1(3):283-92. PubMed ID: 6208129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
    Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
    Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody-defined human lung cell surface protein antigens.
    Mazauric T; Mitchell KF; Letchworth GJ; Koprowski H; Steplewski Z
    Cancer Res; 1982 Jan; 42(1):150-4. PubMed ID: 7053844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
    Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
    Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1.
    Kawakami Y; Battles JK; Kobayashi T; Ennis W; Wang X; Tupesis JP; Marincola FM; Robbins PF; Hearing VJ; Gonda MA; Rosenberg SA
    J Immunol Methods; 1997 Mar; 202(1):13-25. PubMed ID: 9075767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole cell ELISA for detection of tumor antigen expression in tumor samples.
    Erdile LF; Smith D; Berd D
    J Immunol Methods; 2001 Dec; 258(1-2):47-53. PubMed ID: 11684122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical and biochemical characterizations of two monoclonal antibody-reacting antigens associated with human bladder carcinoma.
    Zhang DS; Lin CW
    Cancer Res; 1989 Dec; 49(23):6621-8. PubMed ID: 2819713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigens.
    Berd D; Herlyn M; Koprowski H; Mastrangelo MJ
    Cancer Res; 1989 Dec; 49(23):6840-4. PubMed ID: 2582430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies.
    Bystryn JC; Jacobsen JS; Liu P; Heaney-Kieras J
    Hybridoma; 1982; 1(4):465-72. PubMed ID: 6208141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the NIH workshop monoclonal antibodies to human melanoma antigens.
    Kantor RR; Ng AK; Giacomini P; Ferrone S
    Hybridoma; 1982; 1(4):473-82. PubMed ID: 6208142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
    Badcock G; Pigott C; Goepel J; Andrews PW
    Cancer Res; 1999 Sep; 59(18):4715-9. PubMed ID: 10493530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-melanoma monoclonal antibody HMB-45 on enhanced chemiluminescence-western blotting recognizes a 30-35 kDa melanosome-associated sialated glycoprotein.
    Chiamenti AM; Vella F; Bonetti F; Pea M; Ferrari S; Martignoni G; Benedetti A; Suzuki H
    Melanoma Res; 1996 Aug; 6(4):291-8. PubMed ID: 8873048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of minimal disease in patients with solid tumors.
    Pantel K
    J Hematother; 1996 Aug; 5(4):359-67. PubMed ID: 8877711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of the canine melanoma antigen recognized by the murine monoclonal antibody IBF9 and its distribution in cultured canine melanoma cell lines.
    Oliver JL; Wolfe LG; Lopez MK; Church-Bird A; Toivio-Kinnucan M; Dietrich MA
    Am J Vet Res; 1997 Jan; 58(1):46-52. PubMed ID: 8989495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody SK1-mediated cytotoxicity against colon cancer cells.
    Chang HR; Chavoshan B; Park H
    Dis Colon Rectum; 1993 Dec; 36(12):1152-7. PubMed ID: 8253013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches.
    Morgan AC; Woodhouse C; Bartholemew R; Schroff R
    Mol Immunol; 1986 Feb; 23(2):193-200. PubMed ID: 2422545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.